Literature DB >> 29419411

Correlation of immunohistochemical mismatch repair protein status between colorectal carcinoma endoscopic biopsy and resection specimens.

Odharnaith O'Brien1, Éanna Ryan2, Ben Creavin2, Michael E Kelly2, Helen M Mohan2, Robert Geraghty1, Des C Winter2, Kieran Sheahan1.   

Abstract

BACKGROUND: Microsatellite instability is reflective of a deficient mismatch repair system (dMMR), which may be due to either sporadic or germline mutations in the relevant mismatch repair (MMR) gene. MMR status is frequently determined by immunohistochemistry (IHC) for mismatch repair proteins (MMRPs) on colorectal cancer (CRC) resection specimens. However, IHC testing performed on endoscopic biopsy may be as reliable as that performed on surgical resections. AIM: We aimed to evaluate the reliability of MMR IHC staining on preoperative CRC endoscopic biopsies compared with matched-surgical resection specimens.
METHODS: A retrospective search of our institution's histopathology electronic database was performed. Patients with CRC who had MMR IHC performed on both their preoperative endoscopic biopsy and subsequent resection from January 2010 to January 2016 were included. Concordance of MMR staining between biopsy and resection specimens was assessed.
RESULTS: From 2000 to 2016, 53 patients had MMR IHC performed on both their preoperative colorectal endoscopic biopsy and resection specimens; 10 patients (18.87%) demonstrated loss of ≥1 MMRP on their initial endoscopic tumour biopsy. The remainder (81.13%) showed preservation of staining for all MMRPs. There was complete agreement in MMR IHC status between the preoperative endoscopic biopsies and corresponding resection specimens in all cases (κ=1.000, P<0.000) with a sensitivity of 100% (95% CI 69.15 to 100) and specificity of 100% (95% CI 91.78 to 100) for detection of dMMR.
CONCLUSION: Endoscopic biopsies are a suitable source of tissue for MMR IHC analysis. This may provide a number of advantages to both patients and clinicians in the management of CRC. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  colorectal cancer; histopathology; immunohistochemistry; molecular pathology

Mesh:

Substances:

Year:  2018        PMID: 29419411     DOI: 10.1136/jclinpath-2017-204946

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  7 in total

1.  Evaluating Mismatch Repair/Microsatellite Instability Status Using Cytology Effusion Specimens to Determine Eligibility for Immunotherapy.

Authors:  Elizabeth M Jacobi; Gene Landon; Russell R Broaddus; Sinchita Roy-Chowdhuri
Journal:  Arch Pathol Lab Med       Date:  2020-03-30       Impact factor: 5.534

2.  Evaluating utility and feasibility of mismatch repair testing of colorectal cancer patients in a low-middle-income country.

Authors:  Inas Elsayed; Robert Geraghty; Salwa O Mekki; Ahmed A Mohamedani; Susan Ahern; Omer E H Salim; Balgis B M Khalil; Sawsan Abdelrahim; Suliman H Suliman; Moawia M A Elhassan; Salah O Salah; Mohamed E Salih; Abubakr H Widatalla; Osman S Abdelhamed; Xiaosheng Wang; Éanna J Ryan; Des Winter; Salih Bakhiet; Kieran Sheahan
Journal:  Sci Rep       Date:  2022-06-29       Impact factor: 4.996

3.  Universal Screening of Gastrointestinal Malignancies for Mismatch Repair Deficiency at Stanford.

Authors:  Aser Abrha; Navika D Shukla; Rachel Hodan; Teri Longacre; Shyam Raghavan; Colin C Pritchard; George Fisher; James Ford; Sigurdis Haraldsdottir
Journal:  JNCI Cancer Spectr       Date:  2020-06-19

4.  Evaluating Mismatch Repair/Microsatellite Instability Status Using Cytology Effusion Specimens to Determine Eligibility for Immunotherapy.

Authors:  Elizabeth M Jacobi; Gene Landon; Russell R Broaddus; Sinchita Roy-Chowdhuri
Journal:  Arch Pathol Lab Med       Date:  2021-01-01       Impact factor: 5.686

5.  Identifying patients with Lynch syndrome using a universal tumor screening program in an integrated healthcare system.

Authors:  Philip R Crain; Jamilyn M Zepp; Sara Gille; Lindsay Jenkins; Tia L Kauffman; Elizabeth Shuster; Katrina A B Goddard; Benjamin S Wilfond; Jessica Ezzell Hunter
Journal:  Hered Cancer Clin Pract       Date:  2022-04-18       Impact factor: 2.164

6.  Detection of Microsatellite Instability in Colonoscopic Biopsies and Postal Urine Samples from Lynch Syndrome Cancer Patients Using a Multiplex PCR Assay.

Authors:  Rachel Phelps; Richard Gallon; Christine Hayes; Eli Glover; Philip Gibson; Ibrahim Edidi; Tom Lee; Sarah Mills; Adam Shaw; Rakesh Heer; Angela Ralte; Ciaron McAnulty; Mauro Santibanez-Koref; John Burn; Michael S Jackson
Journal:  Cancers (Basel)       Date:  2022-08-08       Impact factor: 6.575

7.  Optimizing the Personalized Care for the Management of Rectal Cancer: A Consensus Statement.

Authors:  Erman Aytaç; Leyla Özer; Bilgi Baca; Emre Balık; Yersu Kapran; Orhun Cığ Taşkın; Başak Oyan Uluç; Mehmet Ufuk Abacıoğlu; Murat Gönenç; Yasemin Bölükbaşı; Barbaros E Çil; Bülent Baran; Cem Aygün; Mehmet Erdem Yıldız; Kemal Ünal; Burçak Erkol; Tunç Yaltı; Uğur Özbek; Tan Attila; Nurdan Tözün; Bengi Gürses; Sibel Erdamar; Özlem Er; Nuran Beşe; Orhan Bilge; Güralp Onur Ceyhan; Nil Molinas Mandel; Uğur Selek; Cengiz Yakıcıer; Hülya Kayserili Karabey; Murat Saruç; Volkan Özben; Eren Esen; Emre Özoran; Erkan Vardareli; Levent Güner; İsmail Hamzaoğlu; Dursun Buğra; Tayfun Karahasanoğlu; The İstanbul Group
Journal:  Turk J Gastroenterol       Date:  2022-08       Impact factor: 1.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.